Humana's CEO, James Rechtin, emphasized that 2024 adjusted EPS met initial guidance, including investments in Stars and growth, and reaffirmed the 2025 outlook with a continued focus on achieving a 3% ...

Physicians and scientists from Mayo Clinic's Migraine Research Program are working to better understand, treat and prevent migraines by examining the role of genetics and environment in migraine, and ...